Your browser is no longer supported. Please, upgrade your browser.
Settings
XOMA XOMA Corporation daily Stock Chart
XOMA [NASD]
XOMA Corporation
Index- P/E- EPS (ttm)-0.12 Insider Own0.30% Shs Outstand8.73M Perf Week9.54%
Market Cap237.66M Forward P/E- EPS next Y-1.05 Insider Trans- Shs Float8.15M Perf Month13.61%
Income-0.70M PEG- EPS next Q-0.28 Inst Own53.90% Short Float6.69% Perf Quarter10.43%
Sales19.60M P/S12.13 EPS this Y-318.90% Inst Trans25.73% Short Ratio7.10 Perf Half Y65.27%
Book/sh2.95 P/B9.23 EPS next Y-377.30% ROA-2.70% Target Price45.00 Perf Year94.43%
Cash/sh4.55 P/C5.99 EPS next 5Y19.00% ROE-9.00% 52W Range11.58 - 28.85 Perf YTD-0.29%
Dividend- P/FCF- EPS past 5Y43.80% ROI-40.60% 52W High-5.65% Beta1.29
Dividend %- Quick Ratio4.40 Sales past 5Y-31.60% Gross Margin- 52W Low135.06% ATR1.18
Employees10 Current Ratio4.40 Sales Q/Q888.90% Oper. Margin-16.50% RSI (14)67.50 Volatility4.49% 4.54%
OptionableNo Debt/Eq1.27 EPS Q/Q161.70% Profit Margin-10.30% Rel Volume0.68 Prev Close25.01
ShortableYes LT Debt/Eq1.11 EarningsMar 05 BMO Payout- Avg Volume76.73K Price27.22
Recom2.20 SMA2012.68% SMA508.94% SMA20036.09% Volume51,849 Change8.84%
Jan-18-18Reiterated H.C. Wainwright Buy $38 → $49
Oct-17-17Resumed H.C. Wainwright Buy $38
Sep-05-17Upgrade Wedbush Neutral → Outperform $9 → $19
Jun-12-17Initiated H.C. Wainwright Buy $15
Nov-14-16Downgrade Wedbush Outperform → Neutral $17 → $14
Mar-11-16Reiterated Wedbush Outperform $6 → $3
Jul-23-15Downgrade Jefferies Buy → Hold
Jul-22-15Downgrade Piper Jaffray Overweight → Neutral
Jul-22-15Downgrade Ladenburg Thalmann Buy → Neutral
Oct-10-14Resumed ROTH Capital Buy $9
Apr-29-14Upgrade MLV & Co Hold → Buy $7
Mar-11-14Downgrade MLV & Co Buy → Hold $8 → $7
Mar-05-14Reiterated Ladenburg Thalmann Buy $6.50 → $10
Oct-31-13Reiterated MLV & Co Buy $7.50 → $8
May-09-13Reiterated Ladenburg Thalmann Buy $5 → $6
May-14-12Initiated Cowen & Co Outperform
Mar-31-11Reiterated MLV Capital Buy $12 → $10
Mar-23-11Reiterated RBC Capital Mkts Outperform $8 → $6
Jan-06-11Reiterated Ladenburg Thalmann Buy $12 → $16
Jan-04-11Reiterated Wedbush Outperform $12 → $16
Jan-22-20 01:02PM  Before You Buy XOMA Corporation (NASDAQ:XOMA), Consider Its Volatility Simply Wall St.
Dec-26-19 07:12AM  Will XOMA Continue to Surge Higher? Zacks
Dec-23-19 04:00PM  Should You Avoid XOMA Corp (XOMA)? Insider Monkey +13.39%
Dec-20-19 04:35PM  XOMA Announces Closing of Rights Offering GlobeNewswire
Dec-16-19 09:34AM  5 Biotech Stocks Set for Continued Rally in 2020 Zacks
Dec-05-19 05:04PM  Iscalimab (CFZ533) Update GlobeNewswire
Dec-02-19 04:30PM  XOMA Announces Commencement of Rights Offering GlobeNewswire
Nov-19-19 04:30PM  XOMA Announces Proposed Rights Offering GlobeNewswire
Nov-13-19 06:47AM  Will XOMA Continue to Surge Higher? Zacks
Nov-05-19 08:20AM  XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results GlobeNewswire +7.34%
Oct-30-19 10:33AM  Will Xoma (XOMA) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-15-19 03:39PM  How Much Are XOMA Corporation (NASDAQ:XOMA) Insiders Spending On Buying Shares? Simply Wall St.
Sep-27-19 07:56AM  The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave Benzinga
Sep-26-19 04:07PM  XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets GlobeNewswire
08:27AM  XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-12-19 01:37PM  What Did XOMA Corporation's (NASDAQ:XOMA) CEO Take Home Last Year? Simply Wall St.
Sep-03-19 08:00AM  XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-13-19 08:30AM  Health Check: How Prudently Does XOMA (NASDAQ:XOMA) Use Debt? Simply Wall St.
Aug-12-19 07:30AM  XOMAs Royalty Portfolio Expands Significantly GlobeNewswire
Aug-06-19 10:05AM  Xoma (XOMA) Reports Q2 Loss, Tops Revenue Estimates Zacks -5.72%
07:30AM  XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results GlobeNewswire
Jul-30-19 03:16PM  A Firm's First Profit Can Mean Big Returns for Investors Zacks
10:38AM  Analysts Estimate Xoma (XOMA) to Report a Decline in Earnings: What to Look Out for Zacks
06:30AM  XOMA to Present at the 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-09-19 02:07PM  What Kind Of Share Price Volatility Should You Expect For XOMA Corporation (NASDAQ:XOMA)? Simply Wall St.
Jun-13-19 06:45AM  First Patient Dosed with Gevokizumab in Collaborator Clinical Study in Metastatic Colorectal Cancer, Gastroesophageal Cancer, and Renal Cell Carcinoma GlobeNewswire
Jun-07-19 09:25AM  If You Had Bought XOMA (NASDAQ:XOMA) Stock Five Years Ago, You'd Be Sitting On A 81% Loss, Today Simply Wall St.
May-06-19 07:55PM  Xoma (XOMA) Surpasses Q1 Earnings and Revenue Estimates Zacks
06:43PM  Xoma: 1Q Earnings Snapshot Associated Press
04:30PM  XOMA Reports First Quarter 2019 Financial Results and Operating Highlights GlobeNewswire
May-01-19 10:33AM  Will Xoma (XOMA) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-12-19 05:20PM  Portland biotech inks $9M+ deal for drug royalties American City Business Journals
Apr-11-19 12:14PM  Is XOMA Corporation's (NASDAQ:XOMA) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Apr-08-19 06:00AM  XOMA Acquires Royalty Rights to Five Hematology Candidates GlobeNewswire
Apr-03-19 07:00AM  XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference GlobeNewswire +6.44%
Mar-07-19 07:05AM  XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights GlobeNewswire
Mar-05-19 07:00AM  XOMA to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-21-19 05:48PM  Stealth rally happening in value stocks, is the trend here to stay CNBC Videos
Feb-13-19 07:00AM  XOMA Receives $5.5 Million Payment from Rezolute GlobeNewswire +13.82%
Feb-04-19 07:28AM  How Much Are XOMA Corporation (NASDAQ:XOMA) Insiders Spending On Buying Shares? Simply Wall St.
Jan-03-19 04:35PM  XOMA Announces Barbara Kosacz Joins its Board of Directors GlobeNewswire
Dec-18-18 04:43PM  XOMA Announces Closing of Rights Offering GlobeNewswire
Nov-19-18 04:30PM  XOMA Announces Commencement of Rights Offering GlobeNewswire
Nov-07-18 11:55AM  Xoma (XOMA) Reports Q3 Loss, Tops Revenue Estimates Zacks +8.35%
10:52AM  Xoma: 3Q Earnings Snapshot Associated Press
07:05AM  XOMA Announces Proposed Rights Offering GlobeNewswire
07:00AM  XOMA Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-30-18 08:05AM  Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors GlobeNewswire
Oct-29-18 10:31AM  Xoma (XOMA) Q3 Earnings Preview: What's Shaping Up? Zacks
Oct-25-18 08:15AM  Analysis: Positioning to Benefit within Middlesex Water, On Deck Capital, New Relic, Toro, XOMA, and ESCO Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -7.49%
Sep-27-18 04:30PM  XOMA to Present at the Cantor Fitzgerald Healthcare Conference 2018 and the 2018 BIO Investor Forum GlobeNewswire -6.07%
Sep-24-18 12:15PM  The XOMA Corporation (NASDAQ:XOMA) Ownership Structure Could Be Important Simply Wall St. +5.68%
Sep-21-18 07:00AM  XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte GlobeNewswire
Aug-28-18 07:00AM  XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference GlobeNewswire
Aug-09-18 07:00AM  XOMA to Present at the 2018 Wedbush PacGrow Healthcare Conference and the 2018 Southern California Investor Conference GlobeNewswire
Aug-07-18 06:15PM  Xoma (XOMA) Reports Q2 Loss, Lags Revenue Estimates Zacks
05:08PM  Xoma: 2Q Earnings Snapshot Associated Press
04:35PM  XOMA Reports Second Quarter 2018 Financial Results GlobeNewswire
07:40AM  Detailed Research: Economic Perspectives on Alleghany, Enable Midstream Partners, LP, XOMA, MCBC, Unifi, and Tyler Technologies What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-26-18 07:00AM  XOMA Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire
May-15-18 07:00AM  XOMA to Present at the UBS Global Healthcare Conference GlobeNewswire
May-09-18 06:11PM  Xoma: 1Q Earnings Snapshot Associated Press
04:05PM  XOMA Reports First Quarter 2018 Financial Results GlobeNewswire
May-08-18 07:00AM  XOMA Announces $20 Million Credit Facility with Silicon Valley Bank to Advance Royalty-Aggregator Business Model GlobeNewswire
May-02-18 07:30AM  New Research: Key Drivers of Growth for HTG Molecular Diagnostics, Impinj, XOMA, Stock Yards, TriCo Bancshares, and Alleghany Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-03-18 07:00AM  XOMA to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire +5.89%
Mar-20-18 07:35AM  Investor Expectations to Drive Momentum within Key Energy Services, XOMA, Goldman Sachs BDC, Echo Global Logistics, Ellington Residential Mortgage REIT, and Phibro Animal Health Discovering Underlying Factors of Influence GlobeNewswire
Mar-07-18 05:46PM  Xoma reports 4Q loss Associated Press +7.78%
04:05PM  XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update GlobeNewswire
Mar-05-18 07:00AM  XOMA to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-19-18 10:04AM  AbbVie Presents New Data on Upadacitinib for Crohn's Disease Zacks
Feb-16-18 09:56AM  FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review Zacks
Feb-14-18 05:48PM  AVEO (AVEO) to Get $2 Million from EUSA Pharma for Fotivda Zacks
Feb-08-18 11:26AM  Theravance, J&J Ink Deal for Inflammatory Intestinal Drug Zacks
09:49AM  Keryx (KERX) Loss Wider Than Expected in Q4, Stock Down Zacks
Feb-06-18 10:00AM  Pfizer Files for Xtandi in Early Stage Prostate Cancer Zacks
Feb-02-18 10:00AM  Puma, CANbridge Team Up to Commercialize Nerlynx in China Zacks
09:30AM  Alnylam's (ALNY) RNAi Candidate's NDA Gets Priority Review Zacks
Jan-31-18 09:17AM  Puma & Medison Team Up to Commercialize Nerlynx in Israel Zacks
Jan-30-18 11:14AM  Theravance's NDA for COPD Candidate Gets FDA Acceptance Zacks
Jan-29-18 10:22AM  Glaxo's Shingles Vaccine Shingrix Gets Positive CHMP Opinion Zacks
Jan-26-18 03:54PM  East Bay drug maker soars 700 percent on Wall Street with plan to NOT make drugs American City Business Journals
Jan-25-18 10:30AM  Dr. Reddy's (RDY) Q3 Earnings Fall, Revenues Improve Y/Y Zacks
10:29AM  Shire Gets FDA Nod for Cinryze Tech Transfer to New Site Zacks
Jan-24-18 03:22PM  EU Unlikely to Approve Puma's Nerlynx in 2018, Stock Down Zacks
Jan-23-18 11:30AM  3 Pharma and Biotech Stocks to Watch Out for in 2018 InvestorPlace
10:45AM  Anthera's Sollpura Strong on Positive Futility in Phase III Zacks
09:42AM  Regeneron's Dupixent Receives MHLW Nod for Label Expansion Zacks
Jan-22-18 10:22AM  Bristol-Myers (BMY) Reports Data from CheckMate-142 Study Zacks
08:43AM  Acorda Therapeutics (ACOR) Jumps: Stock Rises 8.8% Zacks
Jan-17-18 09:36AM  Novo Nordisk's (NVO) Hits 52-Week High: What's Driving It? Zacks
07:35AM  Recent Analysis Shows XOMA, Washington Real Estate Investment Trust, TransMontaigne Partners, Triumph, Hemispherx BioPharma, and Virtus Investment Partners Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-15-18 08:15AM  3 Pharma and Biotech Stocks to Watch Out for in 2018 Zacks
Jan-12-18 12:46PM  Aradigm's Bronchiectasis Candidate Has Negative FDA Vote Zacks
10:05AM  Perrigo (PRGO) Hits 52-Week High: What's Driving the Stock? Zacks
Jan-11-18 09:46AM  Vertex's Cystic Fibrosis Drug Ok'd for Pediatric Use in EU Zacks
08:01AM  Why is Novo Nordisk Stock Up More Than 50% in Past Year? Zacks
Jan-10-18 09:00AM  Adamas (ADMS) Launches Dyskinesia Drug in the US, Stock Up Zacks
Jan-09-18 04:35PM  Acorda's Shares Down on Disappointing Ampyra View for 2018 Zacks
09:58AM  Novo Nordisk Confirms Bid for Ablynx But Faces Rejection Zacks
XOMA Corporation, a biotech company, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include X213, an allosteric inhibitor of prolactin action; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; IL-2, a therapy for metastatic melanoma and renal cell carcinoma; and PTH1R, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy. The company also licenses antibody discovery, optimization, and development technologies. It has research and development collaboration agreements with Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; Rezolute, Inc.; and Takeda Pharmaceutical Company Limited. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BVF PARTNERS L P/IL10% OwnerDec 19Buy22.00373,1958,210,2901,147,676Dec 20 07:18 PM
Neal James RCEONov 06Option Exercise5.504,34823,91422,017Nov 08 04:30 PM
Neal James RCEONov 06Sale22.004,34895,65617,669Nov 08 04:30 PM
Neal James RChief Executive OfficerSep 20Option Exercise5.505,45229,98623,121Sep 20 07:40 PM
Neal James RChief Executive OfficerSep 20Sale20.235,452110,27117,669Sep 20 07:40 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 19Option Exercise4.034,17116,80910,726Sep 20 07:39 PM
Neal James RChief Executive OfficerSep 19Option Exercise5.506,37035,03524,039Sep 20 07:40 PM
Neal James RChief Executive OfficerSep 19Sale21.126,370134,54417,669Sep 20 07:40 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 19Sale21.414,17189,2966,555Sep 20 07:39 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 18Option Exercise4.033,82915,43110,384Sep 20 07:39 PM
Neal James RChief Executive OfficerSep 18Option Exercise5.503,83021,06521,499Sep 20 07:40 PM
Neal James RChief Executive OfficerSep 18Sale21.963,83084,11317,669Sep 20 07:40 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 18Sale21.963,82984,0916,555Sep 20 07:39 PM
BVF PARTNERS L P/IL10% OwnerMay 14Buy14.7413,816203,664746,454May 14 09:01 PM
BVF PARTNERS L P/IL10% OwnerMay 13Buy14.363,79754,526732,638May 14 09:01 PM
BVF PARTNERS L P/IL10% OwnerMay 10Buy14.5710,300150,037728,841May 14 09:01 PM
VAN NESS W DENMANDirectorMay 10Sale14.711301,9120May 14 06:38 PM